IOmx
Description: iOmx develops first-in-class cancer therapies targeting novel immune checkpoint modulators on tumor cells through systematic screening.
Country: Germany
Based in: Germany
Founded: 2016
Funding Stage: Series A/B
Tags: ['health', 'cancer', 'health tech']
ACCESS DIRECTORY
Details about how we process your information are available in our Privacy Policy.
